IO Biotech holder reports 6.3% ownership stake
IO Biotech, Inc. investor Jorey Chernett filed Amendment No. 1 to a Schedule 13G reporting beneficial ownership of 4,543,532 shares of IO Biotech common stock, representing 6.3% of the class as of December 31, 2025.
Rhea-AI Filing Summary
IO Biotech, Inc. investor Jorey Chernett filed Amendment No. 1 to a Schedule 13G reporting beneficial ownership of 4,543,532 shares of IO Biotech common stock, representing 6.3% of the class as of December 31, 2025.
Chernett reports sole voting and dispositive power over all 4,543,532 shares, with no shared voting or investment authority and no membership in a filing group. The certification states that the shares were not acquired to change or influence control of IO Biotech.
Positive
- None.
Negative
- None.
FAQ
What ownership stake in IO Biotech (IOBT) does Jorey Chernett report?
What type of SEC filing did Jorey Chernett submit for IO Biotech (IOBT)?
What is the effective date of Jorey Chernett’s reported IO Biotech (IOBT) holdings?
Is Jorey Chernett seeking to influence control of IO Biotech (IOBT)?
AI-generated analysis. How Rhea-AI works. Not financial advice.